Does CARFILZOMIB Cause Thrombocytopenia? 1,265 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,265 reports of Thrombocytopenia have been filed in association with CARFILZOMIB (KYPROLIS). This represents 5.8% of all adverse event reports for CARFILZOMIB.
1,265
Reports of Thrombocytopenia with CARFILZOMIB
5.8%
of all CARFILZOMIB reports
284
Deaths
385
Hospitalizations
How Dangerous Is Thrombocytopenia From CARFILZOMIB?
Of the 1,265 reports, 284 (22.5%) resulted in death, 385 (30.4%) required hospitalization, and 173 (13.7%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
Diarrhoea (764)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which CARFILZOMIB Alternatives Have Lower Thrombocytopenia Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL